GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Duearity AB (OSTO:DEAR) » Definitions » YoY EBITDA Growth

Duearity AB (OSTO:DEAR) YoY EBITDA Growth : -99.61% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Duearity AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Duearity AB's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was -99.61%.

Duearity AB's EBITDA per Share for the three months ended in Dec. 2023 was kr-0.51.


Duearity AB YoY EBITDA Growth Historical Data

The historical data trend for Duearity AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duearity AB YoY EBITDA Growth Chart

Duearity AB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -1,258.95 3.10 -6.79

Duearity AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.26 51.49 11.03 -66.67 -99.61

Duearity AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Duearity AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-1.336--1.251)/ | -1.251 |
=-6.79 %

Duearity AB's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (Q: Dec. 2023 )
=(EBITDA per Share (Q: Dec. 2023 )-EBITDA per Share (Q: Dec. 2022 )) / | EBITDA per Share (Q: Dec. 2022 )) |
=(-0.507--0.254)/ | -0.254 |
=-99.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Duearity AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Duearity AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Duearity AB (OSTO:DEAR) Business Description

Traded in Other Exchanges
Address
Krusegrand 42D, Malmo, SWE, 212 25
Duearity AB is a medical technology company. It develops smallest and flexible products and services for tinnitus under the Tinearity brand.

Duearity AB (OSTO:DEAR) Headlines